Production (Stage)
Legend Biotech Corporation
LEGN
$35.00
$3.5211.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 725.29M | 620.98M | 514.11M | 450.18M | 339.35M |
| Total Other Revenue | 3.02M | 6.26M | 6.07M | 5.81M | 3.45M |
| Total Revenue | 728.30M | 627.24M | 520.18M | 455.99M | 342.80M |
| Cost of Revenue | 665.69M | 648.13M | 607.90M | 596.25M | 561.63M |
| Gross Profit | 62.61M | -20.88M | -87.72M | -140.26M | -218.84M |
| SG&A Expenses | 300.54M | 284.26M | 263.52M | 233.15M | 216.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 966.23M | 932.39M | 871.43M | 829.40M | 778.55M |
| Operating Income | -237.93M | -305.15M | -351.24M | -373.41M | -435.76M |
| Income Before Tax | -197.48M | -158.13M | -345.46M | -287.07M | -467.93M |
| Income Tax Expenses | 20.67M | 18.89M | 2.67M | -2.05M | -1.99M |
| Earnings from Continuing Operations | -218.15 | -177.03 | -348.13 | -285.01 | -465.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -218.15M | -177.03M | -348.13M | -285.01M | -465.95M |
| EBIT | -237.93M | -305.15M | -351.24M | -373.41M | -435.76M |
| EBITDA | -227.46M | -293.40M | -339.65M | -361.52M | -424.46M |
| EPS Basic | -2.38 | -1.94 | -3.82 | -3.13 | -5.21 |
| Normalized Basic EPS | -0.65 | -0.53 | -1.18 | -0.99 | -1.64 |
| EPS Diluted | -2.38 | -1.94 | -3.82 | -3.14 | -5.22 |
| Normalized Diluted EPS | -0.67 | -0.54 | -1.18 | -0.99 | -1.64 |
| Average Basic Shares Outstanding | 732.97M | 731.21M | 729.72M | 727.97M | 720.63M |
| Average Diluted Shares Outstanding | 375.52M | 374.65M | 364.86M | 363.99M | 360.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |